CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Grant or award Director acquired 3,896 shares (grant or award)
- 4 Grant or award Director acquired 4,130 shares (grant or award)
- 4 Grant or award Director acquired 7,793 shares (grant or award)
- 4 Grant or award Director acquired 857 shares (grant or award)
- 4 Planned sale EVP, General Counsel sold 220 shares at $7.38 ($1,624)
- 144 Insider Sale of Securities
- 8-K/A Event Exhibits
- 4 Planned sale EVP, General Counsel sold 43 shares at $7.61 ($327)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 836 shares (grant or award)
- 4 Grant or award Director acquired 3,801 shares (grant or award)
- 4 Grant or award Director acquired 7,603 shares (grant or award)
- 4 Grant or award Director acquired 4,029 shares (grant or award)
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation
Page 12 of 121 · 2,419 filings